Immunotherapy in HER2-positive breast cancer: state of the art and future perspectives von Krasniqi, E, Barchiesi, G, Pizzuti, L, Mazzotta, M, Venuti, A, Maugeri-Saccà, M, Sanguineti, G, Massimiani, G, Sergi, D, Carpano, S, Marchetti, P, Tomao, S, Gamucci, T, De Maria, R, Tomao, F, Natoli, C, Tinari, N, Ciliberto, G, Barba, M, Vici, P

Volltext

BAROCCO: A randomized phase II study of weekly paclitaxel vs cediranib-olaparib with continuous schedule vs cediranib-olaparib with intermittent schedule in advanced platinum resis... von Colombo, N., Nicoletto, O., Benedetti Panici, P., Tognon, G., Lissoni, A.A., Bologna, A., Tomao, F., Fossati, R., Tettamanzi, F., Rulli, E., Galli, F., Alvisi, M.F., Torri, V., Biagioli, E.

Volltext

P23.05: Accuracy of pelvic ultrasound in preoperative evaluation of uterine myomas: a prospective cohort study von Perniola, G., Martoccia, A., Casorelli, A., Romito, A., Caccetta, J., Fischetti, M., Lecce, F., Tomao, F., Di Donato, V., Muzii, L., Benedetti Panici, P.

Volltext

Total laparoscopic radical hysterectomy and pelvic lymphadenectomy in locally advanced stage IB2-IIB cervical cancer patients after neoadjuvant chemotherapy von Vizza, E, Pellegrino, A, Milani, R, Fruscio, R, Baiocco, E, Cognetti, F, Savarese, A, Tomao, F, Chen, C, Corrado, G

Volltext

Modified gluteal fold advancement V-Y flap for vulvar reconstruction after surgery for vulvar malignancies von Musella, A, Bracchi, C, Palaia, I, Bellati, F, Tomao, F, Besharat, A, Visentin, S, Benedetti Panici, P

Volltext

Fertility drugs and breast cancer risk von Lo Russo, G, Tomao, F, Spinelli, G P, Prete, A A, Stati, V, Panici, P Benedetti, Papa, A, Tomao, S

Volltext

M372 INCIDENCE OF AMENORRHEA IN PREMENOPAUSAL WOMEN WITH BREAST CANCER (BC) UNDERGOING CHEMOTHERAPY (CT) WITH ANTHRACYCLINE (A), CYCLOPHOSPHAMIDE (C) AND DOCETAXEL (T) von Basso, E., Rossi, L., Tomao, F., Papa, A., Zaccarelli, E., Spinelli, G.P., Russo, G. Lo, Zoratto, F., Strudel, M., Stati, V., Tomao, S.

Volltext

Immunogenicity of Allo-Vesicle Carrying ERBB2 Tumor Antigen for Dendritic Cell-Based Anti-Tumor Immunotherapy von Napoletano, C., Rughetti, A., Landi, R., Pinto, D., Bellati, F., Rahimi, H., Spinelli, G.P., Pauselli, S., Sale, P., Dolo, V., De Lorenzo, F., Tomao, F., Benedetti-Panici, P., Frati, L., Nuti, M.

Volltext

Evaluation of CA125 and HE4 diagnostic performance in hereditary and sporadic ovarian cancer von Tartaglione, S., Manganaro, L., Di Trani, M., Viggiani, V., Tomao, F., Angeloni, A., Anastasi, E.

Volltext

Migrant women and cervical cancer: background of a prevention study von Mariani, L, Morrone, A, Preti, M, Sbiroli, C, Tomao, F, Tomao, S

Volltext

Targeted drug delivery via folate receptors in recurrent ovarian cancer: a review von Marchetti, Claudia, Palaia, Innocenza, Giorgini, Margherita, De Medici, Caterina, Iadarola, Roberta, Vertechy, Laura, Domenici, Lavinia, Di Donato, Violante, Tomao, Federica, Muzii, Ludovico, Benedetti Panici, Pierluigi

Volltext

Hemoglobin variation and blood transfusion rates in patients affected by locally advanced cervical cancer undergoing neo-adjuvant chemotherapy followed by radical surgery: the role... von Bellati, F, Pernice, M, Manci, N, Palaia, I, Tomao, F, Marchetti, C, Zullo, MA, Muzii, L, Angioli, R, Panici, P. Benedeth

Volltext

BAROCCO: A randomized phase II study of weekly paclitaxel vs cediranib-olaparib combination given with continuous or intermittent schedule in patients with recurrent platinum resis... von Colombo, N., Nicoletto, M.O., Benedetti Panici, P., Tognon, G., Bologna, A., Lissoni, A.A., DeCensi, A., Tomao, F., Fossati, R., Tettamanzi, F., Rulli, E., Galli, F., De Luca, M., Alvisi, M.F., Mancari, R., Ratti, M., Baldoni, A., Torri, V., Biagioli, E.

Volltext

LBA58 - BAROCCO: A randomized phase II study of weekly paclitaxel vs cediranib-olaparib combination given with continuous or intermittent schedule in patients with recurrent platin... von Colombo, N., Nicoletto, M.O., Benedetti Panici, P., Tognon, G., Bologna, A., Lissoni, A.A., DeCensi, A., Tomao, F., Fossati, R., Tettamanzi, F., Rulli, E., Galli, F., De Luca, M., Alvisi, M.F., Mancari, R., Ratti, M., Baldoni, A., Torri, V., Biagioli, E.

Volltext

1002TiPBAROCCO: A randomized phase II study of weekly paclitaxel vs cediranib-olaparib with continuous schedule vs cediranib-olaparib with intermittent schedule in advanced platinu... von Colombo, N, Nicoletto, O, Benedetti Panici, P, Tognon, G, Lissoni, A A, Bologna, A, Tomao, F, Fossati, R, Tettamanzi, F, Rulli, E, Galli, F, Alvisi, M F, Torri, V, Biagioli, E

Volltext

LBA58BAROCCO: A randomized phase II study of weekly paclitaxel vs cediranib-olaparib combination given with continuous or intermittent schedule in patients with recurrent platinum... von Colombo, N, Nicoletto, M O, Benedetti Panici, P, Tognon, G, Bologna, A, Lissoni, A A, DeCensi, A, Tomao, F, Fossati, R, Tettamanzi, F, Rulli, E, Galli, F, De Luca, M, Alvisi, M F, Mancari, R, Ratti, M, Baldoni, A, Torri, V, Biagioli, E

Volltext

Primary prophylaxis of neutropenia in women affected by breast cancer undergoing adjuvant chemotherapy with fec 100 +/- docetaxel: comparison of efficacy and tolerability between l... von Rossi, L., Papa, A., Tomao, F., Caruso, D., Ricci, F., Verrico, M., Giordani, E., Perrone Congedi, F., Giannarelli, D., Zaccarelli, E., Minozzi, M., Spinelli, G.P., Stati, V., Tomao, S.

Volltext

Trastuzumab in metastatic breast cancer von Tomao, F, Miele, E, Spinelli, G P, Russillo, M, La Ferla, G, Tomao, S

Volltext

Retroperitoneal schwannoma presenting as an ovarian tumor von Tomao, F, Mariani, L, Miele, E, Spinelli, G P, Tomao, S

Volltext

First-Line Treatment with Olaparibfor Early Stage BRCA-Positive Ovarian Cancer: May It Be Possible? Hypothesis Potentially Generating a Line of Research von Tomao F, Boccia SM, Sassu CM, Chirra M, Palaia I, Petrella MC, Di Donato V, Colombo N, Benedetti Panici P

Volltext